Impact of neoadjuvant treatments on morbidity and oncological outcome of patients with NSCLC

Major Symposium
Chairs: H-B. Ris (Lausanne, Switzerland), C. Bolliger (Tygerberg, South Africa)

Impact on noninvasive mediastinal staging J. Vansteenkiste (Leuven, Belgium)
Impact on invasive mediastinal staging P. E. van Schil (Edegem, Belgium)
Impact on recurrence and long-term survival E. Quoix (Strasbourg, France)